UK Renal Trials Network
The UK Renal Trials Network was established to facilitate the design and delivery of nephrology clinical trials in the UK.
The aim of the network is to support investigators in the development and conduct of clinical trials, in order to improve treatments for patients living with kidney disease. Through establishing and maintaining links with other international renal networks, the network aims to facilitate the delivery of global randomised control trials.
Who we are
The UK Renal Trials Network (UKRTN) is jointly led by:
- Dr Thomas Hiemstra, University Lecturer in Trials at the University of Cambridge and Honorary Consultant Nephrologist at Cambridge Clinical Trials Unit based at Addenbrooke’s Hospital
- Dr Will Herrington, Associate Professor in the Renal Studies Group, at the University of Oxford and Honorary Consultant Nephrologist at Oxford Kidney Unit.
Members of the UKRTN have expertise in trial design, conduct, analysis and reporting. It includes clinical trialists, statisticians, a health economist, trial manager, trials research nurse specialists, epidemiologists and patient experts.
We aim to improve the quality and number of UK nephrology trials and provide trial expertise and support to all members of the UK renal research community.
The UKRTN meets three times a year and invites submission of proposals for new trials at an early stage in development. Proposers are welcome to attend our meetings and have the opportunity to discuss their proposal with members of the network. Written feedback is provided where required, and we can write in support of grant applications.
Dates of forthcoming meetings:
23 September 2019
We review an average of four new proposals at each meeting. Almost 30 proposals have been reviewed to date of which 11 have been funded. Most of those not yet funded remain in the work-up phase.
We have conducted work on the practical aspects of trial conduct, including co-enrolment in trials and standardisation of patient reported outcome measures in trials.
Since the Network was established in 2015, we have contributed to several major successful funding bids for definitive trials in dialysis, transplantation and glomerulonephritis, chronic kidney disease and imaging.
For more information and to find out about getting involved as a patient or researcher, contact: